Buy or sell uBiome stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies

uBiome Stock
DNA sequencing
About uBiome Stock
uBiome is the world’s first effort to map the human microbiome with citizen science.
While the sequencing of the human genome has provided invaluable knowledge, it is very difficult to change their own genetic makeup. The microbiome, in contrast, is much more easily changed through simple means such as healthful probiotic cultures and other lifestyle interventions. The microbiome thus may provide some of the most important medical breakthroughs of their era. uBiome will ultimately empower participants to manage their microbiomes to improve their health as well as make important scientific discoveries for humanity.
Investors
Andreessen Horowitz
Lyft, Robinhood, Databricks, Airbnb, Instacart, Magic Leap, Stripe, Anduril Industries, Rappi, CoinSwitch Kuber
Funding History
July 2014 | $120K |
---|---|
August 2014 | $4.5M |
Management
Cofounder and CEO
Jessica Richman
Cofounder and CTO
Zachary Apte
Press
Forbes - Oct, 2 2019
Wall Streets Journal - Sep, 6 2019
Forbes - Sep, 4 2019
Wall Streets Journal - Jul, 11 2019
Wall Streets Journal - Jun, 30 2019
Wall Streets Journal - Jun, 24 2019
Wall Streets Journal - May, 16 2019
Wall Streets Journal - May, 1 2019
Wall Streets Journal - Apr, 26 2019
TechCrunch - Apr, 17 2019
TechCrunch - Sep, 21 2018
TechCrunch - Mar, 20 2015
Crowdfund Insider - Jan, 21 2014
Fast Company - Oct, 29 2013
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase